Rheumatoid Arthritis Nosode

Product NDC

43742-0492

11-digit product format

437420492

Labeler code

43742

Product ID

43742-0492_b4119275-536d-48af-8a60-398872575365

Type

HUMAN OTC DRUG

Nonproprietary name

Adenosinum Triphosphoricum Dinatrum, Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, DHEA (Dehydroepiandrosterone), Streptococcus Viridans, Borrelia Burgdorferi Nosode, Brucella Abortus, Calcarea Carbonica, Campylobacter Jejuni, Chlamydia Trachomatis, Klebsiella Pheumoniae, Mycoplasma Pneumoniae, Yersinia Enterocolitica, Pneumococcinum, Streptococcus Agalactiae, Enterococcus Faecalis, Streptococcus Mutans, Salmonella Enteritidis, Dysentery Bacillus, Shigella Sonnei

Dosage form

LIQUID

Route

ORAL

Labeler

Deseret Biologicals, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2014-06-21

Marketing end

2022-11-30

Substance

ADENOSINE TRIPHOSPHATE DISODIUM; APIOLE (PARSLEY); BORRELIA BURGDORFERI; BRUCELLA ABORTUS; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; CINNAMIC ACID; ENTEROCOCCUS FAECALIS; KLEBSIELLA PNEUMONIAE; MALIC ACID; MYCOPLASMA PNEUMONIAE; OROTIC ACID MONOHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PRASTERONE; PROTEUS MORGANII; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; SODIUM DIETHYL OXALACETATE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP; YERSINIA ENTEROCOLITICA

Active strength

6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record